tiprankstipranks
Acasti Pharma, Inc. (ACST)
NASDAQ:ACST

Acasti Pharma (ACST) Stock Forecast & Price Target

1,128 Followers
See the Price Targets and Ratings of:

ACST Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Acasti
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ACST Stock 12 Month Forecast

There Are No Analyst Ratings for ACST In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ACST Financial Forecast

ACST Earnings Forecast

Next quarter’s earnings estimate for ACST is -$0.35 with a range of -$0.35 to -$0.35. The previous quarter’s EPS was -$0.21. ACST beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.24% of the time in the same period. In the last calendar year ACST has Underperformed its overall industry.
Next quarter’s earnings estimate for ACST is -$0.35 with a range of -$0.35 to -$0.35. The previous quarter’s EPS was -$0.21. ACST beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.24% of the time in the same period. In the last calendar year ACST has Underperformed its overall industry.

ACST Sales Forecast

Next quarter’s sales forecast for ACST is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ACST beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.55% of the time in the same period. In the last calendar year ACST has Underperformed its overall industry.
Next quarter’s sales forecast for ACST is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ACST beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.55% of the time in the same period. In the last calendar year ACST has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum
Buy
Assigned
02/13/24
Acasti Pharma (ACST) Gets a Buy from Craig-Hallum
H.C. Wainwright
$12.00
Buy
272.02%
Upside
Reiterated
10/17/23
Analysts Offer Insights on Healthcare Companies: Acasti Pharma (NASDAQ: ACST), Omnicell (NASDAQ: OMCL) and MoonLake Immunotherapeutics (NASDAQ: MLTX)
Oppenheimer
Buy
Reiterated
07/10/23

Best Analysts Covering Acasti Pharma

Which Analyst Should I Follow If I Want to Buy ACST and Sell After:
1 Month
Leland GershellOppenheimer
Success Rate
5/11 ratings generated profit
45%
Average Return
-8.17%
reiterated a buy rating 11 months ago
Copying Leland Gershell's trades and holding each position for 1 Month would result in 45.45% of your transactions generating a profit, with an average return of -8.17% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Leland GershellOppenheimer
Success Rate
5/11 ratings generated profit
45%
Average Return
-8.72%
reiterated a buy rating 11 months ago
Copying Leland Gershell's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of -8.72% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Leland GershellOppenheimer
Success Rate
1/11 ratings generated profit
9%
Average Return
-49.15%
reiterated a buy rating 11 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -49.15% per trade.
2 Years
Leland GershellOppenheimer
Success Rate
1/11 ratings generated profit
9%
Average Return
-53.65%
reiterated a buy rating 11 months ago
Copying Leland Gershell's trades and holding each position for 2 Years would result in 9.09% of your transactions generating a profit, with an average return of -53.65% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ACST Analyst Recommendation Trends

Rating
Dec 22
Feb 23
Jul 23
Oct 23
Feb 24
Strong Buy
3
4
5
3
3
Buy
2
1
1
1
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
6
4
5
In the current month, ACST has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ACST average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ACST Stock Forecast FAQ

What is ACST’s average 12-month price target, according to analysts?
Currently, no data Available
What is ACST’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ACST, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ACST a Buy, Sell or Hold?
      Currently, no data Available
      What is Acasti Pharma, Inc.’s price target?
      Currently, no data Available
      What do analysts say about Acasti Pharma, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ACST?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis